Moreover, TGF-β signaling also drives MDSCs to differentiate into pro-tumorigenic terminally-differentiated myeloid mononuclear cells, which contribute to angiogenesis, immune suppression, and tumor progression [84] (Figure 4). Here, TGFB1 is linked to neoplasm.